18F-FDG PET/CT for Very Early Response Evaluation Predicts CT Response in Erlotinib-Treated Non–Small Cell Lung Cancer Patients: A Comparison of Assessment Methods
暂无分享,去创建一个
A. Khalil | J. Frøkiær | P. Meldgaard | K. Hjorthaug | Anne Winther-Larsen | J. Fledelius | A. Bertelsen | Catharina M Bylov | Aksel Bertelsen